News | News By Subject | News by Disease News By Date | Search News

Ophthalmics (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Novartis AG (NVS) and Google (GOOG)’s Verily Miss Smart Contact Lens Human Trial Goal     11/22/2016
SoCal's Aerie (AERI) Stock Soars Over the Rainbow on Positive Phase III Eye Drug Data     9/16/2016
Primary Endpoint Met in pSivida (PSDV)’s First Medidur Phase III     8/16/2016
Spark Therapeutics (ONCE) Touts Long-Term Positive Phase III Gene Therapy Data     8/11/2016
FDA Spurns Ocular Therapeutix (OCUL)'s Post-Operative Eye Pain Treatment     7/25/2016
FDA Rejects Valeant (VRX) Glaucoma Drug, Raises Concerns Over Manufacturing Issues     7/22/2016
Shire (SHPG) Soars After the FDA Approves Long-Awaited Dry-Eye Disease Drug     7/12/2016
Google (GOOG)'s DeepMind Tries to Spot Eye Conditions with Artificial Intelligence     7/5/2016
Shire (SHPG)'s Retinopathy Treatment Fails to Meet Primary Endpoint in Phase II     7/1/2016
Amid Insider Trader Investigations, Acucela (AUCL) and Otsuka Pharma Kill Glaucoma Drug Deal After Failed Trial     6/14/2016
Once Floated as Allergan (AGN) Target, Revance (RVNC)'s Stock Drops as Crow’s Feet Drug Fails Trial     6/14/2016
Noveome Debuts with Top-Line Data from Three Phase I Clinical Trials     4/13/2016
Regeneron (REGN), Bayer (BAY) Partner Up to Develop Novel Combo Therapy for Eye Diseases     3/24/2016
Embattled Bay Area XOMA  (XOMA) Terminates Gevokizumab Trials     3/14/2016
Aldeyra Therapeutics (ALDX)'s Eye Drug Effective in Phase IIa Study     2/29/2016

News from Around the Web
An Audacious Vision: Researchers Aim For First Human Eye Transplant Within The Decade     11/23/2016
Novartis AG (NVS) Is Gearing Up For A Huge Makeover     11/17/2016
Innovative Approaches In Ocular Drug Delivery     11/14/2016
Pixium Vision's Iris II Brings Back Sight To Blind For First Time     11/10/2016
On Front Lines Of Price Dispute, Eye Doctors Wary Of New Drug Data     11/2/2016
Smoking Pot May Give You Better Night Vision     11/1/2016
Endomag, European Device Makers Eye U.S. Amid Regulatory Changes     10/27/2016
An Online Vision-Test Startup Is Suing For The Right To Operate, Opternative Reveals     10/21/2016
Scleral Implants Improve Presbyopia Out To 3 Years     10/20/2016
University of Houston Researchers Develop Glucose-Sensing Contact Lens     10/6/2016
World’s First Robotic Eye Surgery Is A Milestone For Biomedical Tech     9/27/2016
Diabetic Macular Edema: Dexamethasone Implant May Improve Vision, IRCCS Study     9/27/2016
Israeli Researcher Invents Devices Allowing Blind People To "See" Via Vibrations, Sounds, Hebrew University of Jerusalem Study     9/16/2016
No More Readers? New Implant May Help Aging Eyes, UCLA Study     9/14/2016
Vitamin A Compound Retinoic Acid May Help Fight Colorectal Cancer Risk, Stanford University Study     9/2/2016

Press Releases
RightEye Developing Revolutionary Eye-Tracking Test For Reading Disorders     12/6/2016
EyeGate Pharma Reports Positive Data From Third Stage Of Phase Ib/IIa Clinical Trial Of EGP-437 In Cataract Surgery Patients     12/5/2016
Eyenovia Announces Publication Of Phase II Study Results Demonstrating Benefits Of Micro-Formulation Over Conventional Eyedroppers And Addition Of Scientific Advisory Board Members     11/29/2016
Santen Pharma Announces Phase III SAKURA Program Topline Results In Patients With Non-Infectious Uveitis Of The Posterior Segment     11/28/2016
Portfolio Company TopiVert Receives IND Approval For TOP1630 In The Treatment Of Dry Eye Syndrome     11/28/2016
Omeros (OMER) Announces Successful Outcome Of OMIDRIA Pediatric Cataract Trial     11/21/2016
RegeneRx Biopharmaceuticals, Inc. (RGRX) Announces First Patients Enrolled In Phase 3 U.S. Dry Eye Clinical Trial (ARISE-2 Trial) With RGN-259     11/10/2016
Pixium Vision Announces The First Successful Implantation And Activation Of IRIS II, 150 Electrode Bionic Vision System, In The UK     11/7/2016
PAVmed (PAVM) Partners With Harvard, Tufts University To Develop Revolutionary Ear Device     11/4/2016
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice Of Allowance For Patent For Tß4 Eye Drop Formulation     11/3/2016
Allergan (AGN) Introduces RESTASIS MULTIDOSE (Cyclosporine Ophthalmic Emulsion) 0.05%, A New Delivery System For The One And Only FDA Approved Treatment To Help Patients Produce More Of Their Own Tears     10/28/2016
Imprimis (immy)' Dropless Therapy Shows Significant Advantages In A Large Peer-Reviewed Study     10/25/2016
EyeQue Introduces World’s Most Advanced Intelligent Vision Solution     10/24/2016
American Academy of Ophthalmology Release: Wearable Artificial Vision Device Shows Promise In Helping People Who Are Legally Blind "Read"     10/18/2016
SciFluor Life Sciences, LLC Announces First Patients Dosed In Retinal Program With Investigational New Drug Application For SF0166 Topical Ophthalmic Solution     10/17/2016